Valuation: Ray Co., Ltd.

Market Cap 66.39B 49.78M 44.58M 41.01M 37.16M 69.45M 4.73B 70.75M 489M 196M 2.49B 187M 183M 7.84B P/E 2026 *
6.54x
P/E 2027 * 5.59x
Enterprise Value 121M 90.79K 81.31K 74.79K 67.77K 127K 8.62M 129K 892K 358K 4.53M 341K 333K 14.3M EV / Sales 2026 *
0.98x
EV / Sales 2027 * 0.73x
Free-Float
65.73%
Yield 2026 *
-
Yield 2027 * -
09-14 Graphy Inc. completed the acquisition of 15.35% stake in Ray Co., Ltd. from Lee Sang-cheol and Ray Holdings Co., Ltd. CI
09-09 Graphy Inc. signed of Share Transfer Agreement to acquire 15.35% stake in Ray Co., Ltd. from Lee Sang-cheol and Ray Holdings Co., Ltd. for KRW 28.9 billion. CI
12-22 Ray Co., Ltd. agreed to acquire LACHELLE for KRW 5 billion. CI
25-09-21 Ray Co., Ltd.(KOSDAQ:A228670) dropped from S&P Global BMI Index CI
24-03-26 Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co.,Ltd, L&C BIO Co.,LTD, Samsung Securities Co.,Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd. CI
24-03-24 Ray Co., Ltd. announced that it expects to receive KRW 25 billion in funding from KB Securities Co.,Ltd, L&C BIO Co.,LTD, Samsung Securities Co.,Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd. and other investors CI
23-05-12 Ray Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
21-04-21 Ray Co., Ltd. announced that it has received KRW 31.5 billion in funding CI
21-04-19 Ray Co., Ltd. announced that it expects to receive KRW 31.5 billion in funding CI
20-11-18 Optical Biosystems, Inc. announced that it has received $20 million in funding from a group of investors CI
19-12-23 Ray Co., Ltd.(KOSDAQ:A228670) added to S&P Global BMI Index CI
19-12-23 Ray Co., Ltd.(KOSDAQ:A228670) added to S&P Global BMI Index CI
19-08-07 Ray Co., Ltd. has completed an IPO in the amount of KRW 20 billion. CI
1 day-1.16%
1 week-4.28%
1 month-3.30%
3 months-15.27%
6 months-51.82%
Current year-37.30%
1 week 4,170
Extreme 4170
4,495
1 month 4,110
Extreme 4110
4,675
Current year 3,680
Extreme 3680
11,690
1 year 3,680
Extreme 3680
11,690
3 years 3,680
Extreme 3680
25,700
5 years 3,680
Extreme 3680
42,150
10 years 3,680
Extreme 3680
42,150
Manager TitleAgeSince
Chief Executive Officer 53 2014-12-31
Director of Finance/CFO - -
Chief Operating Officer - 2024-10-16
Director TitleAgeSince
Director/Board Member 53 2014-12-31
Director/Board Member 57 2022-03-27
Director/Board Member 57 2024-10-16
Date Insider Type Main position Quantity % Market Cap. Importance
4/14/25 Buy 1,000 0.0064%
4/1/25 Buy 500 0.0032%
4/1/25 Buy 500 0.0032%
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%-4.28%-19.14%-78.12% 49.78M
-1.72%+3.44%+22.84%+56.71% 258B
-2.00%+0.75%+7.82%+20.94% 163B
-3.73%-4.48%-19.14%+64.75% 150B
-1.66%-8.12%-58.32%-17.99% 60.84B
-.--%+2.46%-11.69%-7.41% 53.31B
-2.57%+3.30%+11.59%+44.40% 53.03B
+0.84%-3.12%+7.47%+62.40% 50.67B
-3.47%+1.04%+19.48%+69.17% 49.3B
-3.61%+1.99%+32.36%+93.99% 45.46B
Average -1.91%-0.60%-0.67%+30.88% 88.4B
Weighted average by Cap. -2.10%+0.15%+4.03%+44.65%

Financials

2026 *2027 *
Net sales 124B 93.06M 83.34M 76.66M 69.46M 130M 8.84B 132M 914M 367M 4.65B 349M 342M 14.66B 147B 110M 98.7M 90.79M 82.26M 154M 10.46B 157M 1.08B 435M 5.5B 414M 405M 17.36B
Net income 10.89B 8.17M 7.31M 6.73M 6.1M 11.4M 775M 11.61M 80.23M 32.21M 408M 30.65M 30M 1.29B 13.07B 9.8M 8.78M 8.08M 7.32M 13.68M 931M 13.93M 96.3M 38.66M 490M 36.79M 36.01M 1.54B
Net Debt 54.7B 41.01M 36.73M 33.78M 30.61M 57.22M 3.89B 58.29M 403M 162M 2.05B 154M 151M 6.46B 40.77B 30.56M 27.37M 25.18M 22.81M 42.64M 2.9B 43.44M 300M 121M 1.53B 115M 112M 4.81B
Projected Income Statement - Annual - Ray Co., Ltd.
Logo Ray Co., Ltd.
Ray Co Ltd is a Korea-based company principally engaged in the manufacturing of dental medical device equipment business. The Company operates its business through two segments. The Digital Therapy Solutions segment is engaged in providing digital therapy solutions and three-dimensional (3D) form printer solutions. The Digital Diagnostic Systems segment is engaged in the manufacture and sale of medical devices such as pano imaging devices and ceph imaging devices. The Company sells its products in domestic and overseas markets.
Employees
163
Date Price Change Volume
26-10-30 ₩4,245.00 -1.16% 35,285
26-10-29 ₩4,295.00 -2.16% 18,556
26-10-28 ₩4,390.00 +0.46% 17,017
26-10-27 ₩4,370.00 -0.46% 12,013
26-10-26 ₩4,390.00 -1.01% 27,382
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Ray Co., Ltd.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
4,245.00KRW
Average target price
12,500.00KRW
Spread / Average Target
+194.46%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ray Co., Ltd.
  1. Stock Market
  2. Stocks
  3. A228670 Stock